Replies to post #115872 on Liquidmetal Technologies Inc (LQMT)

[Tlsmd]

I would say so William A. Below is one of the clips from all the information available to us on the Internet. He seems to want to spread out around the Worlld. He has made footprints in CHINA, INDIA ! EUROPE, here in The USA through LQMT and recently in BRAZIL. That Is nothing to sneeze at. I feel he is QUITE the BUSINESS MAN. Where I feel LQMT will benefit is from receiving orders from one or more of Professor Li's Companies for castings of Joint Replacement parts and who knows what else. Maybe even a Pacemaker type
Monitor for the heart. This is what I like about what is taking shape From each company he has he can probably order parts from LQMT. In reverse he orders the Machinery FOR LQMT FROM Eontec. Great planning. Well let us see if we test that .30 barrier on Friday. I feel this one is going to be tougher than .26 and the recent .29 but TWT. Thanks for your input William A. Please scroll. Tlsmd

LSGTissuesProductsTechnologiesQualityEventsNewsEMCM current newsEMCM news archiveCareersHomeAbout EMCMMediaContact

New corporate strategy bears first fruit

Leader Biomedical has furthermore unveiled its own corporate identity and website.

The new corporate identity centres on the idea of “Extending your Reach” by increasing the access of next generation healthcare solutions to global markets, with an emphasis on high-growth emerging markets. Since the announcement of our strategy last year, Leader Biomedical has already started to deliver on this promise by setting up subsidiaries in India and China and consolidating its marketing and sales operations in Amsterdam, the Netherlands. Finally, it has also entered into a partnership with Dora Medikal to promote its proprietary eCOO® Technology in Turkey. All these initiatives are in line with European Medical Contract Manufacturing or EMCM’s business strategy and will help it in its mission of becoming a centre for manufacturing excellence.

“Leader Biomedical was established to be a leading provider of biomaterials and medical implants with a strong footprint in high-growth markets, like China,” said Prof. Lugee Li, Founder and sole shareholder of Leader Biomedical.

“Through hard work and dedication, we’ve been able to move quickly and I am very pleased with the progress we have made. This is however only the beginning and you can expect more exciting news in the near future,” he continues.

Ultimately, Leader Biomedical’s ambition is to develop an integrated value chain encompassing new technological innovations, Manufacturing Operations (CMO & OEM), which will be EMCM’s main focus, and product marketing.

Leader Biomedical was founded by Prof. Li following the acquisitions of EMCM and aap Joints. The new corporate identity will bring these subsidiaries – along with future acquisitions – together under a single umbrella, uniting them through a common mission and vision.

We invite you to visit our new corporate website and contact us if you have any questions.

Terms and conditions|Privacy policy|copyright © 2017 emcm B.V.